دراسة التعدد الشكلي لجين Angiotensin I Converting enzyme لدى النساء المصابات بمرض السكري النوع الثاني.

-Wild S, Roglic G, Green A, Sicree R, King H.(2004) . Global Prevalence of Diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care.; 27: 1047-1053.

-González EL, Johansson S, Wallander MA, Rodríguez LA (2009). Trends in the prevalence and incidence of diabetes in the UK: 1996 – 2005. J. Epidemiol. Community Health. 63: 332-336.

-Rask-Madsen, C. and Kahn ,C. R..(2012). Tissue–specific insulin signaling, metabolic syndrome, and cardiovascular disease,” Arteriosclerosis, Thrombosis, and Vascular Biology, 32, (9): 2052–2059.

- Kaku K (2010). Pathophysiology of type 2 diabetes and its treatment policy. JMAJ, 53(1):41-46.

- Karabulut , A; Turgut,S ; Turgut, G.(2010 ). Angiotensin converting enzyme gene insertion /deletion polymorphism in patients with polycystic ovary syndrome . Gynecol. Endocrinol.26 (6): 393-398.

- Riordan, JF.(2003). Angiotensin-I-converting enzyme and its relatives. Genome Biol;4:225. 6.

- Wang, Y.; Peng, W.; Zhang, X.; Qiao,H.; Wang, L.; Xu, Z. and Wu, Ch. (2016). The association of ACE gene polymorphism with diabetic kidney disease and renoprotective efficacy of valsartan. Journal of the Renin-Angiotensin- Aldosterone System: 1–6.

- Lopes – Virella , M.F .et al.,(1977). clinical chemistry.,23:882.

- Garrow, J.S. and Webster, J. (1985). Quetelts index (W/H2) as a measure of fatness. Inter. J. Obesit. 9: 147-153.

- Sambrook,J. ; Fritsch,E.F.; and Maniatis,T. (1989). Molecular cloning: A laboratory manual . 2nd edition, Cold spring harbor laboratory press,cold spring Harbor, New York.

- Naresh, V.V.S.; Reddy,A.L.K; Sivaramakrishna,G;Sharma,P.V.G;Vardhan,R.V. and Kumar,V.(2009). angiotensin converting enzyme gene polymorphisms in Type II diabetics with nephropathy. Indian Journal of Nephrology,19(14):145-148.

- Basu R., Breda E., Oberg A., Powell C., Man P., Basu A., Vittone J. Klee G., Arora P.Jenson and Rizza A.(2003) Mechanisms of the age- associated deterioration in glucose tolerance: contribution of alterations in insulin secretion action and clearance ., Diabetes, 52 (7) : 1738 – 1748 .

- Mehta, K.N. Parik K.H. Chag. M.C., Shah V.G. (2003). Effect of Treatment on homocysteine Mia in cardiac patients: a prospective study. Indian J. of Pharma. 35(5):410.

- Maghrani, M. Lemhadri, A. Zeggwagh, N.A. and Eddouks, M. (2004). Effect of retama raetam on lipid metabolism in normal and recentonset diabetic rates. Journal of Ethnopharmacology V(90):323-329.

-Maechler, P., Wollheim C., Bentzen, C. and Niesors E. (1993). Importance of exogenous cholesterol in diabetic rates: effect of treatment with insulin deficiency or with an Acyl-coA: cholersterol acyltrance ferase-inhibtor. Ann. Nutr. Metab., 37: 199-209.

- Steyn, , NP., Mann, J ., Bennett, PH., Temple, N., Zimmet, P., Tuomilehto,J., Lindstrom,J. and Louheranta, A.(2004). Diet, nutrition and the prevention of type 2 diabetes, Public Health Nutrition: 7(1A), 147–165.

- Zinah, A U. A. and Mahmood, Sh.Z.(2011). The Association Between Body Mass Index, Lipid Profile and Serum Estradiol Levels in a Sample of Iraqi Diabetic remenopausal Women. Oman Medical Journal., 26(4): 263- 266.

-الأشيال، عبد الأمير عبد الله (2009), الداء السكري الوقاية منه والطرق العلاجية الحديثة للسيطرة الشاملة ، الجزء الثالث الطبعة الأولى ، كلية طب المستنصرية ، الشؤون الثقافية العامة ، بغداد .

-Bury,J.E.;Stroup,J.S.;Stephens,J.R.andBaker,D.L.(2007). Achieving American diabetes association goals in HIV- seropositive Patients with diabetes mellitus . Proc. Bayl. Univ. Med.Cent. 20:118-123.

-Iwase, T.; Nakanishi, S. ; Nishi, Y. ; Ishiwata, S.; Komiyama, N. and Nishiyoma, S.(1998) .Relation between evaluation of IHD and changes in lipid profile. J. Cardiol. 32: 227-233.

- Solini, H.; Vestra, M.D.; Saller. A.; Nosadini R.; Crepaldi, G.and Fioretto, P. (2002). The angiotensin-converting enzyme DD genotype is associated with glomerulopathy lesions in T2D. Diab, 51(1): 251-55.

- Turgut, G.; Akin, F., Turgut, S., Dursunoğlu, D., Karasu, U. & Gur, S. (2009). ACE gene polymorphism and cardiac structure in patients with insulin resistance. Mol Biol Rep; 36:623-9.

-Nikzamir,A.R.;Golmohammadi,T.;Nakhjavani,M.;Zahtaei,M. and Amirzargar,A.A. (2006). Angiotensin converting enzyme gene polymorphism in Iranian Patients With Type 2 Diabetes.Iran.J.Immunol.3(1):23-29.

- Ruggenenti P, Bettinaglio, P.; Pinares, F. et al.( 2008). Angiotensin converting enzyme insertion/deletion polymorphism and renoprotection in diabetic and nondiabetic nephropathies. Clin J Am Soc Nephrol; 3: 1511–1525.

- Al-Serri, A.; Ismael, F.G.; Al-Bustan, S.A.and Al-Rashdan, I. (2015).Association of the insertion allele of the common ACE gene polymorphism with type 2 diabetes mellitus among Kuwaiti cardiovascular disease patients. J Renin-Angiotensin-Aldosterone Syst.;16:910–6.

- Stephens, J.W., Dhamrait, S.S.; Cooper, J.A.; Acharya, J.; Miller, G.J.; Hurel, S.J.and Humphries, S.E. (2005). The D allele of the ACE I/D common gene variant is associated with type 2 diabetes mellitus in Caucasian subjects. Mol. Genet. Metab., 84: 83-89.

- Pereira,A.C.; Mota,G.A.; Benseñor,I.; Lotufo,P.A. and Krieger1,J.E. (2001). Effect of race, genetic population structure, and genetic models in two-locus association studies: clustering of functional renin-angiotensin system gene variants in hypertension association studies. Braz J Med Biol Res 34(11):1421-1428 .